Witkiewitz, K., Anton, R. F., O’Malley, S. S., Hasin, D. S., Silverman, B. L., Aldridge, A., & Mann, K. (2025). Reductions in World Health Organization risk drinking levels as a primary efficacy end point for alcohol clinical trials: A review. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2025.2508
Chicago-Zitierstil (17. Ausg.)Witkiewitz, Katie, Raymond F. Anton, Stephanie S. O’Malley, Deborah S. Hasin, Bernard L. Silverman, Arnie Aldridge, und Karl Mann. "Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials: A Review." JAMA Psychiatry 2025. https://doi.org/10.1001/jamapsychiatry.2025.2508.
MLA-Zitierstil (9. Ausg.)Witkiewitz, Katie, et al. "Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials: A Review." JAMA Psychiatry, 2025, https://doi.org/10.1001/jamapsychiatry.2025.2508.